Association between preoperative nutritional status and mortality in patients with type B aortic dissection undergoing thoracic endovascular aortic repair: a retrospective cohort study Authors: Jiahe Zhang, Shuangshuang Li, Wen Li, Lingxu Kong, Zhichen Ding, Kaiwen Zhao, Jian Zhou Published: 2026 ABSTRACT AbstractBackgroundThe prognostic nutritional index (PNI), which reflects the nutritional and inflammatory status of the body, has been confirmed to be associated with cardiovascular risk, but its prognostic significance in patients with type B aortic dissection (TBAD) undergoing thoracic endovascular aortic repair (TEVAR) is not clear. This study aimed to assess the prognostic value of the PNI in TBAD patients undergoing TEVAR.MethodsA single-center retrospective cohort study was conducted using data from The First Affiliated Hospital of Naval Medical University between January 2009 and July 2023. After screening, 961 patients with TBAD who underwent TEVAR were included. The primary outcome was all-cause death at 1 year after surgery. The outcome was determined by electronic medical record system, follow-up system and telephone follow-up. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cut-off value of PNI for predicting 1-year mortality. Patients were grouped according to the PNI level, and baseline characteristics were compared between the different groups. Univariable and multivariable Cox regression models, restricted cubic spline (RCS) models, and subgroup analysis were utilized to assess the associations between the PNI and clinical outcomes.ResultsA total of 961 patients (mean age 58.69±12.99 years, 82.7% male) were included. The optimal threshold of the PNI obtained from the ROC curve was 46.83. Within 30 days post-TEVAR, 16 patients (1.8%) experienced all-cause mortality, with 13 deaths occurring in the low PNI group and 3 in the high PNI group (P=0.094). Thirty-two aortic-related adverse events (ARAEs) were recorded, with 22 occurring in the low-PNI group and 10 in the high-PNI group (P=0.359). In terms of 1-year outcomes, the cumulative incidence of 1-year all-cause mortality was significantly greater in the low-PNI group than in the high-PNI group, with 7.01% [95% confidence interval (CI): 4.68–9.28] vs. 3.03% (95% CI: 1.15–4.87) (P=0.010). Multivariate Cox regression analysis revealed that the PNI was independently associated with 1-year all-cause mortality [hazard ratio (HR) 0.47; 95% CI: 0.23–0.98, P=0.043]. A U-shaped pattern was found via RCSs.ConclusionsOur study suggests that the PNI was independently associated with 1-year all-cause mortality in TBAD patients undergoing TEVAR, but its clinical application value still needs to be further validated.Keywords: Type B aortic dissection (TBAD), thoracic endovascular aortic repair (TEVAR), prognostic nutritional index (PNI), malnutrition Highlight box Key findings • The prognostic nutritional index (PNI) is a novel and independent predictor of 1-year mortality in patients with type B aortic dissection (TBAD) undergoing thoracic endovascular aortic repair (TEVAR). What is known and what is new? • Existing knowledge has established the association of PNI with outcomes in cardiovascular diseases; however, its specific role in TBAD was previously unclear. • Our study demonstrates that PNI is a significant prognostic indicator for 1-year mortality in TBAD patients post-TEVAR, characterized by a nonlinear (U-shaped) relationship. What is the implication, and what should change now? • PNI is a readily available and clinically useful tool that can improve preoperative risk stratification for TBAD patients scheduled for TEVAR. Identifying high-risk patients (PNI <46.83) allows for targeted nutritional optimization and interventions, which may improve long-term outcomes. Future clinical guidelines should consider incorporating PNI as a routine assessment tool in TBAD management. Introduction Aortic dissection (AD) involves the sudden entry of blood into a false lumen via an intimal tear, potentially resulting in aortic rupture and sudden death (1). Type B aortic dissections (TBADs) occur when the entry tear originates in Zone 1 or further distal regions (2). Thoracic endovascular aortic repair (TEVAR) is a key treatment for TBAD patients and offers significant benefits through effective aortic remodeling via a minimally invasive technique (3). Despite the effectiveness of TEVAR, patients may suffer from postsurgery complications, including stroke, aortic-related adverse events (ARAEs), such as retrograde type A dissections, and organ failure (4). There is an urgent need to identify early warning signs and intervention strategies to improve TEVAR efficacy and patient prognosis. At present, a large number of studies have identified a variety of risk factors related to the prognosis of AD, including demographic characteristics (5), hemodynamic indicators, imaging features (6), etc. The prediction model based on the International Registry of Acute Aortic Dissection (IRAD) patient study (7) provides a simple bedside prediction tool, but it mainly includes variables such as traditional clinical and imaging indicators. Several clinical laboratory markers, such as D-dimer (8), soluble ST2 (9), and the peripheral eosinophil count (10), have been proven to be associated with mortality in TBAD patients. Nutritional status is acknowledged as a pivotal factor influencing patients’ postsurgical outcomes. Furthermore, research indicates that incorporating these laboratory markers can significantly enhance predictive performance (11). The prognostic nutritional index (PNI) is a comprehensive biomarker derived from serum albumin (ALB) levels and peripheral lymphocyte counts and reflects nutritional status, immune function, and inflammation. Recently, the PNI has been increasingly utilized as a predictive marker for outcomes across a range of diseases, including chronic diseases such as kidney disease (12) and critical diseases such as gastric cancer (13). Emerging evidence underscores the clinical importance of the PNI in cardiovascular diseases. In addition to its prognostic importance in individuals with heart failure (14) and stable coronary artery disease (CAD) (15), the PNI is also a predictive marker for early complications and adverse outcomes in adult cardiac surgery patients (16). Previous studies have shown that PNI can be used as an independent predictor of in-hospital mortality after acute type A aortic dissection surgery, and low PNI levels are significantly associated with a higher risk of death (17). However, its prognostic significance in patients with TBAD remains uncertain. From a pathophysiological perspective, the occurrence and progression of AD are characterized by a significant inflammatory response, immune imbalance, and impaired tissue repair capacity (18). As an indicator integrating inflammation, immunity and nutritional status, PNI not only has the potential to reflect the severity of the disease, but also may be involved in the adverse progression of AD to a certain extent. However, its role in TBAD patients, especially in those treated with TEVAR, remains poorly studied. Exploring the effect of PNI on the prognosis of AD is of great significance for improving the current prognosis system of AD. Therefore, this study aimed to assess the perioperative prognostic significance of the PNI in TBAD patients undergoing TEVAR. We present this article in accordance with the STROBE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0218/rc) (19). Methods Study population This study was a single-center retrospective cohort study. A total of 1478 patients with AD who underwent TEVAR in the Aortic Expansion database of The First Affiliated Hospital of Naval Medical University from January 2009 to July 2023 were included. AD was confirmed via computed tomography angiography (CTA). The outcomes after TEVAR were confirmed by medical records, telephone follow-up, and CTA images. Patients aged 18 to 80 years with TBAD who underwent TEVAR were included in the study. Subjects meeting the following criteria were excluded: (I) nonspontaneous AD (n=6); (II) connective tissue disorders (n=11); (III) prior aortic operation (n=13); (IV) current or past cancer (n=75); and (V) incomplete/missing clinical data (n=412) (Figure 1). Due to the retrospective observational nature of this study, no prior sample size estimation was performed. The sample size was determined by the number of consecutive patients who met the inclusion criteria and were enrolled at our center during the study period to reflect real-world clinical practice. The research protocols and statistical analysis methods employed in this study received prior review and approval from the Ethics Committee of The First Affiliated Hospital of Naval Medical University (CHEC-Y2020-042). Informed consent was waived due to the retrospective nature of the study. Clinical trial number is not applicable. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. Flowchart of the patient selection process. PNI, prognostic nutritional index; ROC, receiver operating characteristic. Data collection and definitions The data collected in this study were input by two individuals in a standardized format and subsequently verified through mutual cross-checking. The data included demographic characteristics, comorbidities, laboratory examinations, anatomical characteristics, intraoperative details, and postoperative follow-up, etc. Specific information was sourced from the electronic medical records system, follow-up system, and telephone follow-up communications. During the preliminary data collection and screening phase, variables with a rate of missing data of more than 20% were excluded to mitigate potential bias due to excessively large missing values. According to the Society of Vascular Surgery/Society of Thoracic Surgeons reporting criteria, TBAD was categorized into three stages: acute (1–14 days), subacute (15–90 days), and chronic (>90 days) (20). The PNI was calculated by adding the serum ALB level (g/L) to five times the lymphocyte count (109/L). Patients were stratified into high and low subgroups on the basis of the calculated PNI, with a threshold value of 46.83 used for classification in this study. Among the predictors, body mass index (BMI) was calculated via weight and height measurements, following an internationally recognized formula. Fasting blood samples from all patients were collected and sent to the laboratory of Shanghai Changhai Hospital at 6:00 AM on the day of surgery. This protocol was implemented to ensure consistency in detection time and method, thereby minimizing measurement bias. An automatic hematology analyzer (XN-9000, Sysmex) was used to detect white blood cell count, platelet (PLTs) count and hemoglobin. Biochemical and coagulation parameters such as total cholesterol (TC, mg/dL), triglycerides (TG, mg/dL), and D-dimer (mg/L) were evaluated using an automated biochemical analyzer (Hitachi 7600-120) and a coagulation analyzer (STAGO EVOLUTION). Follow-up procedures and endpoints The qualified investigators meticulously monitored all patients at two distinct intervals, 30 days and 1 year post-surgery. Patients were followed through telephone interviews and outpatient visits, and endpoint events were systematically recorded according to predefined criteria. A systematic review of the complete clinical files of patients who were readmitted or treated as outpatients was performed to identify relevant outcome events. Patients who were lost to follow-up were followed through multiple means, including telephone calls and health system inquiries, when possible. If follow-up information was still not available, we treated them as lost to follow-up in the statistical analysis and censored them in the survival analysis. The endpoints of the study included 30-day all-cause mortality, 1-year all-cause mortality, ARAEs, and major adverse cardiovascular and cerebrovascular events (MACCEs). Among them, ARAEs include various complications such as retrograde AD, aortic rupture, aortic dilatation, malperfusion, and type I or III endoleak. MACCEs include cardiovascular diseases such as non-fatal myocardial infarction and non-fatal stroke. Statistical analysis Continuous data are presented as either the mean ± standard deviation (SD) or median [interquartile range (IQR)], depending on the data distribution, and differences between groups were assessed via Student’s t test or the Mann-Whitney U test, as appropriate. Categorical data are expressed as percentages, with group differences analyzed via the chi-square test or Fisher’s exact test, depending on the expected frequency. Receiver operating characteristic (ROC) curve analysis was employed to determine the optimal cutoff value for diagnostic tests. By calculating the sensitivity and specificity at various threshold points, a ROC curve was constructed to identify the threshold that maximizes the Youden index. This threshold was considered the optimal point for diagnostic performance, as it represents the best balance between sensitivity and specificity, thereby enhancing diagnostic accuracy and reliability. Cox regression models, both univariable and multivariable, were applied to examine the relationships between predictor and outcome variables. Variables with a P value of 0.1 or less in the univariable analysis were initially considered as candidate variables for the multivariable model. The final multivariable model was established with consideration of previous literature, clinical relevance, and potential confounding, rather than relying solely on univariable P values, to minimize confounding bias. To investigate potential nonlinear relationships between the PNI and outcomes, we used generalized additive models with restricted cubic splines (RCSs), which allowed for a more flexible analysis of the data. Subgroup analyses were conducted to assess the robustness of the association between the PNI and outcomes across different patient groups. For missing data, the missing status for each important variable is reported. Statistical analyses were performed via IBM SPSS Statistics version 16, GraphPad Prism version 9, and R version 4.2.0 (http://www.r-project.org). All statistical tests were two-sided, and a significance level of P<0.05 was considered statistically significant for all analyses. Results Clinical characteristics In this vascular department, 1,478 patients were initially screened, 517 of whom were subsequently excluded from the study. As a result, the final analysis included 961 patients (Figure 1). A ROC curve analysis was performed to assess the ability of the PNI to predict 1-year all-cause mortality at admission. After analysis, an optimal cutoff value of 46.83 was identified, which exhibited favorable sensitivity and specificity (Figure 2). ROC curves for the ability of the PNI to predict 1-year all-cause death. AUC, area under the curve; PNI, prognostic nutritional index; ROC, receiver operating characteristic. The cohort was divided into two groups: 586 patients in the PNI <46.83 group and 375 patients in the high PNI group. The mean age of the participants was 58.69 years (SD =12.99), and 82.7% were males. The prevalence of these conditions was as follows: hypertension (75.3%), pleural effusion (32.7%), diabetes mellitus (8.6%), stroke (5.4%), CAD (5.5%), chronic obstructive pulmonary disease (COPD) (10.5%), chronic kidney disease (CKD) (6.1%), and pericardial effusion (6.5%). Additionally, 57% of the patients were in the acute phase. The proximal thrombus of the false lumen was open in 41.2% of the patients, partially occluded in 34%, and completely thrombosed in 14.5%. The low-PNI group demonstrated an obviously lower percentage of male participants (80.7% vs. 85.9%, P=0.039), a decreased BMI (24.19±3.67 vs. 24.78±3.40, P=0.026), and a reduced prevalence of smoking history (53.1% vs. 59.7%, P=0.043). The low PNI group had a greater mean age (P<0.001) and a greater prevalence of comorbidities, including COPD (P=0.042), CKD (P<0.001), pericardial effusion (P=0.003), and pleural effusion (P<0.001). The laboratory data revealed lower PLTs (P=0.007), hemoglobin levels (P<0.001), and TG levels (P<0.001) in the low PNI group. However, D-dimer (P=0.002), creatinine (P<0.001), and glucose levels (P=0.006) were significantly elevated. Intraoperative data revealed that the incidence of TBAD was greater in the acute phase (57%), with 61.3% in the low PNI group and 50.4% in the high PNI group (P<0.001). There was no significant difference between the two groups in terms of branch (P=0.142), adjunct (P=0.156) or hybrid procedures (P=0.798). There were no significant differences in anatomical characteristics, including dissection length (P=0.775), proximal thrombosis status of the false lumen (P=0.563), or involvement of the superior mesenteric (P=0.211), renal (P=0.077), and lower-extremity arteries (P=0.215) (Table 1). Table 1Baseline characteristics of TBAD patients according to the PNI groupsVariableTotal (n=961)PNI <46.83 (n=586)PNI ≥46.83 (n=375)PAge, years58.69±12.9960.73±13.1455.51±12.09<0.001Male795 (82.7)473 (80.7)322 (85.9)0.039BMI, kg/m224.43±3.5724.19±3.6724.78±3.400.026Smoking535 (55.7)311 (53.1)224 (59.7)0.043SBP at admission, mmHg137.55±21.03138.55±21.31135.99±20.530.066DBP at admission, mmHg82.31±11.2882.56±11.7681.92±10.480.391Comorbidities Hypertension724 (75.3)439 (74.9)285 (76.0)0.703 Diabetes mellitus83 (8.6)45 (7.7)38 (10.1)0.186 Stroke52 (5.4)33 (5.6)19 (5.1)0.706 CAD53 (5.5)32 (5.5)21 (5.6)0.927 COPD101 (10.5)71 (12.1)30 (8.0)0.042 CKD59 (6.1)52 (8.9)7 (1.9)<0.001 Pericardial effusion62 (6.5)49 (8.4)13 (3.5)0.003 Pleural effusion314 (32.7)225 (38.4)89 (23.7)<0.001Laboratory tests WBC, ×109/L8.68±3.628.72±3.848.62±3.240.672 Platelet, ×109/L207.31±84.49203.27±86.70213.63±80.630.007 Hemoglobin, g/L128.74±19.25123.08±19.19137.56±15.72<0.001 D-dimer, mg/L3.62±4.664.06±4.782.96±4.390.002 Creatinine, μmol/L104.47±113.55116.64±138.4185.48±50.53<0.001 Glucose, mmol/L6.51±2.536.71±2.876.20±1.830.006 Total cholesterol, mg/dL171.04±41.99168.95±42.20174.05±41.570.109 Triglycerides, mg/dL125.38±89.16113.05±67.12143.09±111.32<0.001 Uric acid, μmol/L325.23±117.16315.79±118.83339.94±113.110.002Intra-operative details Timing of operation<0.001 Acute548 (57.0)359 (61.3)189 (50.4) Sub-acute289 (30.1)178 (30.4)111 (29.6) Chronic123 (12.8)48 (8.2)75 (20.0) Branch168 (17.5)94 (16.0)74 (19.7)0.142 Adjunct175 (18.2)115 (19.6)60 (16.0)0.156 Hybrid14 (1.5)9 (1.5)5 (1.3)0.798Anatomical characteristics Dissection length, mm411.07±144.16414.60±139.94406.96±150.120.775 Proximal thrombosis of FL0.563 Patent396 (41.2)240 (41.0)156 (41.6) Partial327 (34.0)193 (32.9)134 (35.7) Complete139 (14.5)87 (14.8)52 (13.9) ULP99 (10.3)66 (11.3)33 (8.8) Superior mesenteric arteries1 (0.1)0 (0.0)1 (0.3)0.211 Renal arteries33 (3.4)25 (4.3)8 (2.1)0.077 Lower-extremity arteries10 (1.0)25 (4.3)8 (2.1)0.215Values are presented as n (%) or mean ± standard deviation. BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; FL, false lumen; PNI, prognostic nutritional index; SBP, systolic blood pressure; TBAD, type B aortic dissection; ULP, ulcer-like projection; WBC, white blood cell. Baseline characteristics of TBAD patients according to the PNI groups Values are presented as n (%) or mean ± standard deviation. BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; FL, false lumen; PNI, prognostic nutritional index; SBP, systolic blood pressure; TBAD, type B aortic dissection; ULP, ulcer-like projection; WBC, white blood cell. Events at 30 days and 1 year across various PNI groups Table 2 presents the outcomes for participants at two distinct time points, stratified by PNI groups. The mean length of hospital stay was 12.5±6.9 days for those in the low PNI group and 12.2±7.2 days for those in the high-PNI group, with no statistically significant difference (P=0.494). During the 30-day period after TEVAR, 16 patients (1.8%) experienced all-cause mortality, with 13 deaths occurring in the low PNI group and 3 in the high PNI group (P=0.094). A total of 32 ARAEs were recorded, with 22 occurring in the low-PNI group and 10 in the high-PNI group (P=0.359). Six cases of stroke were noted, evenly split between the low-PNI and high-PNI groups (3 cases each, P=0.580). Notably, the cumulative incidence of 1-year all-cause mortality was significantly greater in the low-PNI group than in the high-PNI group [7.01% (95% CI: 4.68–9.28) vs. 3.03% (95% CI: 1.15–4.87), P=0.010]. No statistically significant differences were detected in the occurrence of ARAEs (P=0.615) or MACCEs (P=0.907). Table 2Thirty-day and 1-year outcomes of TBAD patients receiving TEVAR according to the PNI groupsVariablePNI <46.83 (n=586)PNI ≥46.83 (n=375)P valueHospital stays of post-TEVAR, days, mean ± SD12.5±6.912.2±7.20.49430-day outcomes, n (%) 30-day mortality13 (2.2)3 (0.8)0.094 30-day ARAEs22 (3.8)10 (2.7)0.359 30-day stroke3 (0.5)3 (0.8)0.5801-year outcomes (95% CI) Cumulative incidence of 1-year all-cause death, %7.01 (4.68, 9.28)3.03 (1.15, 4.87)0.010 Cumulative incidence of 1-year ARAEs, %12.02 (9.02, 14.93)11.15 (7.67, 14.49)0.615 Cumulative incidence of MACCEs, %2.87 (1.31, 4.41)2.74 (0.95, 4.49)0.907ARAEs, aortic-related adverse events; CI, confidence interval; MACCEs, major adverse cardiovascular and cerebrovascular events; PNI, prognostic nutritional index; SD, standard deviation; TBAD, type B aortic dissection; TEVAR, thoracic endovascular aortic repair. Thirty-day and 1-year outcomes of TBAD patients receiving TEVAR according to the PNI groups ARAEs, aortic-related adverse events; CI, confidence interval; MACCEs, major adverse cardiovascular and cerebrovascular events; PNI, prognostic nutritional index; SD, standard deviation; TBAD, type B aortic dissection; TEVAR, thoracic endovascular aortic repair. Figure 3 depicts the PNI distribution for all-cause mortality at two time points, categorized by survival status. Over the course of 1 year following TEVAR, a significant reduction in the PNI was observed in the deceased cohort compared with the surviving cohort (PNI: 43.29 vs. 45.33, P=0.023). Conversely, there was no statistically significant difference in the PNI between the cohorts in terms of 30-day all-cause mortality (PNI: 44.1 vs. 45.25, P=0.494). Differences in the PNI in patients with different outcomes at (A) 30-day and (B) 1-year intervals. The differences were assessed with the Mann-Whitney U test. PNI, prognostic nutritional index. Impact of the PNI on 1-year mortality, ARAEs and MACCEs Univariate Cox proportional hazards analysis revealed significant associations between 1-year all-cause mortality and the following factors: stroke (P=0.001), CKD (P=0.011), pericardial effusion (P=0.008), superior mesenteric artery involvement (P=0.013), and PNI (P=0.024) (Tables S1,S2). Additionally, univariate Cox proportional hazards modeling for 1-year ARAEs revealed significant differences for stroke (P=0.008) and pericardial effusion (P=0.004). Age, CAD, diabetes, stroke, and CKD were identified as significant predictors of 1-year MACCEs (Table S3). Continuous PNI was found to be linked to 1-year all-cause mortality [hazard ratio (HR) and 95% CI: 0.95 (0.91, 0.99), P=0.024], as analyzed by univariate Cox regression. After adjusting for stroke, CKD, pericardial effusion, and superior mesenteric arteries, the difference was no statistically significant [HR and 95% CI: 0.96 (0.91, 1.01), P=0.098] (Table 3). When the PNI was grouped, a significant difference was observed [HR and 95% CI: 0.47 (0.23, 0.98), P=0.043]. The PNI did not significantly differ between ARAEs and MACCEs, irrespective of whether the data were analyzed as continuous or categorical variables (Table 3). Table 3Association of PNI with 1-year all-cause death, ARAEs and MACCEsVariable Univariate Cox regression modelMultivariate Cox regression model1-year all-cause deathP value1-year ARAEsP value1-year MACCEsP value1-year all-cause deathP valueContinuous PNI 0.95 (0.91, 0.99)0.0240.99 (0.96, 1.02)0.6581.01 (0.95, 1.08)0.6870.96 (0.91, 1.01)0.098PNI groups <46.83ReferenceReferenceReference ≥46.830.41 (0.20, 0.82)0.0120.90 (0.59, 1.36)0.6160.95 (0.41, 2.22)0.9070.47 (0.23, 0.98)0.043Data are presented as HR (95% CI). Covariates for the multivariable model include age, gender, body mass index, smoking, systolic blood pressure, diastolic blood pressure, hypertension, diabetes, stroke, chronic obstructive pulmonary disease, chronic kidney disease, coronary artery disease, timing of operation, pericardial effusion, pleural effusion, superior mesenteric arteries injury, renal artery injury, lower-extremity artery injury. Variables with a P value <0.1 in univariable analysis were entered in the multivariable models (Details in the Tables S1-S3). ARAEs, aortic-related adverse events; CI, confidence interval; HR, hazard ratio; MACCEs, major adverse cardiovascular and cerebrovascular events; PNI, prognostic nutritional index. Association of PNI with 1-year all-cause death, ARAEs and MACCEs Data are presented as HR (95% CI). Covariates for the multivariable model include age, gender, body mass index, smoking, systolic blood pressure, diastolic blood pressure, hypertension, diabetes, stroke, chronic obstructive pulmonary disease, chronic kidney disease, coronary artery disease, timing of operation, pericardial effusion, pleural effusion, superior mesenteric arteries injury, renal artery injury, lower-extremity artery injury. Variables with a P value <0.1 in univariable analysis were entered in the multivariable models (Details in the Tables S1-S3). ARAEs, aortic-related adverse events; CI, confidence interval; HR, hazard ratio; MACCEs, major adverse cardiovascular and cerebrovascular events; PNI, prognostic nutritional index. Kaplan-Meier survival analysis revealed that patients with a PNI score lower than 46.83 experienced significantly poorer survival outcomes than did those with a higher PNI (as evidenced by a P value of 0.01) (Figure 4A). Conversely, no statistically significant disparities were observed in the incidence of 1-year ARAEs or MACCEs between the groups, with P values of 0.615 and 0.907, respectively (Figure 4B,4C). Kaplan-Meier survival analysis of the 1-year outcomes of TBAD patients who underwent TEVAR. (A) The 1-year overall survival probability. (B) The 1-year freedom from ARAEs. (C) The 1-year freedom from MACCEs. ARAEs, aortic-related adverse events; MACCEs, major adverse cardiovascular and cerebrovascular events; PNI, prognostic nutritional index; TBAD, type B aortic dissection; TEVAR, thoracic endovascular aortic repair. The application of RCSs within the Cox proportional hazards model demonstrated nonlinear associations between the PNI and patient outcomes (Figure 5). Specifically, the relationship between the PNI and 1-year all-cause mortality exhibited a U-shaped pattern. The HR for 1-year all-cause mortality increased when the PNI value fell below 45.3; however, the risk plateaued once this threshold was surpassed. Associations between the PNI and 1-year outcomes. (A) Relationships between the PNI and HR for 1-year all-cause mortality. (B) Relationships between the PNI and the HR for 1-year ARAEs. (C) Association between the PNI and 1-year MACCEs. ARAEs, aortic-related adverse events; HR, hazard ratio; MACCEs, major adverse cardiovascular and cerebrovascular events; PNI, prognostic nutritional index. Subgroup analysis was conducted to assess the robustness of the link between the PNI and 1-year outcomes, encompassing factors such as smoking habits, sex, age, systolic and diastolic blood pressure levels, hypertension status, CAD, diabetes mellitus, stroke history, COPD, CKD, and surgical timing. Across all the subgroups, no notable interactions were detected (Figure 6). Subgroup analysis of the associations between the PNI and 1-year outcomes. CAD, coronary artery disease; CI, confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; HR, hazard ratio; PNI, prognostic nutritional index; SBP, systolic blood pressure. Discussion Our study is the first to explore the relationships between different PNI values and the 30-day and 1-year outcomes of TBAD patients. Patients with a PNI below 46.83 face a greater risk of all-cause mortality within 1 year. A Cox proportional hazards model with multivariate analysis confirmed that a higher PNI significantly lowered the risk of all-cause mortality at 1 year, highlighting the independent prognostic significance of the PNI. RCS analysis revealed nonlinear associations between the PNI and 1-year outcomes. Subgroup analysis further confirmed the stability of the research findings. Perioperative nutritional status is linked to dietary intake, malnutrition-related symptoms, body composition data, and nutrition-related laboratory tests (21). In clinical practice, several established tools are employed to assess the preoperative nutritional status of patients (21-23). Nevertheless, these tools exhibit limitations that compromise their clinical applicability. The patient-generated subjective global assessment (PG-SGA) requires subjective assessment, and observer bias may affect its results (23). Nutritional risk screening (NRS-2002) requires information on body weight changes over the past three months and dietary changes over the previous week (24), whereas the nutritional risk index (NRI) requires the patient’s current weight and historical average weight (25). While weight fluctuations, body weight changes, and dietary adjustments are essential for preoperative nutritional assessment, obtaining this information in TBAD patients who are experiencing severe pain and require emergency surgery can be both challenging and time-consuming. Different from traditional indicators, PNI is calculated based on serum ALB and peripheral blood lymphocyte count, which is objective, simple and efficient. It can reflect the overall physiological state of patients in a short time, including the level of inflammation, immune function and nutritional reserve. It can predict postoperative adverse events and complications on the basis of objective variables, effectively identifies high-risk patients, and has significant potential for clinical application. The mechanisms that underlie the relationship between a lower PNI and a poor prognosis in patients with TBAD may be elucidated as follows: first, frailty and functional status may constitute crucial factors, especially among critically ill patients. The underlying frailty and insufficient nutritional reserve of patients have been confirmed to be associated with adverse outcomes after a variety of surgical and cardiovascular interventions. A compromised preoperative nutritional status, as determined by the PNI, has been demonstrated to be correlated with an elevated risk of postoperative kidney injury in elderly patients undergoing major abdominal surgery (26) and percutaneous coronary intervention (27). Owing to the minimally invasive nature of TEVAR, the impact of various risk factors on the prognosis of patients with TBAD tends to be underestimated, particularly compared with that of patients undergoing open surgical procedures. However, a study based on the global registry for endovascular aortic treatment revealed that the 5-year all-cause mortality following endovascular treatment for patients with AD still reached 29%, with the incidence of aortic-related death reaching 4.2% (28). This study indicates that patients with AD appear to be more frail than previously assumed, which can be exacerbated by post-TEVAR weakness. It is essential to facilitate the restoration of systemic physiological functions and aortic integrity through targeted nutritional interventions. Second, a lower PNI is often indicative of systemic inflammation, which can compromise the immune response. As a negative acute phase response protein, ALB synthesis is reduced in inflammatory states, while vascular extravasation occurs due to increased capillary permeability (29). In AD, inflammatory response is considered to be involved in the destruction of aortic wall structure, expansion of false lumen and adverse remodeling process (30). Therefore, low ALB level may indirectly reflect more severe vascular injury and poor repair ability. Previous studies have shown an approximately linear relationship between reduced ALB levels and the risk of cardiovascular events (31). Gao et al. (32) also demonstrated that patients with dissection complicated with hypoalbuminemia had significantly poorer survival. On the other hand, lymphopenia usually indicates that the body is in a state of stress and immunosuppression. In the event of cardiovascular events, activation of the neuroendocrine system can induce apoptosis or redistribution of lymphocytes, which can lead to peripheral lymphopenia and is closely related to poor prognosis (33). In addition, the presence of specific lymphocyte subsets may influence the remodeling of the aortic wall and the progression of dissection (34). Investigating the dynamics of lymphocyte populations in individuals with AD may yield valuable insights into potential therapeutic targets for modulating the immune response, thereby improving patient outcomes. Recent studies have shown that several combined parameters, including lymphocytes, serve as prognostic markers in patients with aortic diseases. An elevated baseline neutrophil-to-lymphocyte ratio (NLR) has been independently correlated with increased subsequent mortality and rehospitalization following transcatheter or surgical aortic valve replacement (35). Furthermore, an elevated NLR has been identified as an independent predictor of both in-hospital mortality and long-term mortality in patients with TBAD undergoing TEVAR (36), indicating that the balance between neutrophils and lymphocytes may be critical in assessing the severity of aortic injury. In summary, the PNI serves as a composite indicator that encapsulates nutritional status as well as systemic and vascular inflammation, and has potential value in risk stratification of patients with TBAD. The incorporation of the PNI into existing prognostic models is expected to increase the accuracy of predictions and improve the prognostic assessment for patients with TBAD. The existing guidelines and consensus lack explicit directives concerning nutritional support for TBAD patients. For TBAD patients who exhibit poor nutritional status, timely intervention through personalized preventive strategies, such as the enrichment of food and fluids, along with dietary counseling and educational interventions, may positively impact postoperative recovery and patient outcomes. Limitations In terms of clinical significance, the current evidence is not sufficient to support the direct use of PNI to guide clinical decision-making. Although PNI is composed of ALB and lymphocytes, which have a certain degree of regulation in theory, which may be improved by nutritional support or inflammation control. However, this study only analyzed the baseline PNI and did not evaluate its dynamic changes, nor could it determine whether the improvement of PNI could translate into benefits for clinical outcomes, and its practical application value in clinical risk assessment still needs further research to verify. Therefore, PNI is more suitable as a risk assessment tool rather than a direct intervention target, and its clinical application value still needs to be verified by further research. In addition, our study was a single-center retrospective design, which inherently has certain limitations, including potential issues with the representativeness of the study population and selection bias. These factors may impact the external generalizability of the findings. Secondly, although the statistical analyses were adjusted for multiple confounders, residual confounding may still exist, such as differences in inflammatory factors, including interleukins, nutritional interventions, and medications that were not included in the analyses. Some key indicators of disease severity, such as false lumen status and aortic anatomical complexity, may not have been adequately adjusted. Thirdly, there may be information bias in the judgment of outcome events, and the completeness of follow-up and loss to follow-up may affect the accuracy of the results. Finally, due to the observational study design, causal inferences cannot be established. Future prospective, multicenter studies are necessary to further validate the association between the PNI and the prognosis of patients with AD. At the same time, we should explore the dynamic changes of PNI and its combined predictive ability with imaging parameters, and evaluate whether intervention strategies targeting PNI can improve clinical outcomes, so as to provide a more reliable basis for optimizing the management of patients with AD. Conclusions The results of our study indicate that poor nutritional status, measured by the PNI, is independently associated with an increased risk of all-cause mortality within 1 year in patients with TBAD after TEVAR. The utilization of this indicator in outcome prediction models has increased their predictive accuracy. Additional studies are necessary to determine whether preoperative malnutrition screening and subsequent care based on these assessments might reduce the occurrence of negative postoperative outcomes. Supplementary The article’s supplementary files as Acknowledgments None. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The research protocols and statistical analysis methods employed in this study received prior review and approval from the Ethics Committee of The First Affiliated Hospital of Naval Medical University (CHEC-Y2020-042). Informed consent was waived due to the retrospective nature of the study. Clinical trial number is not applicable. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. Footnotes Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0218/rc Funding: The study was funded by the National Natural Science Foundation of China (No. 82570560), Scientific Research Cultivation Project of The Third Affiliated Hospital of Naval Medical University (No. 2025QN04), and Clinical Research Special Scientific Research Project funded by the Science and Technology and Economy Commission of Yangpu District (No. YPM202545). Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0218/coif). All authors report that the study was funded by the National Natural Science Foundation of China (No. 82570560), Scientific Research Cultivation Project of The Third Affiliated Hospital of Naval Medical University (No. 2025QN04), and Clinical Research Special Scientific Research Project funded by the Science and Technology and Economy Commission of Yangpu District (No. YPM202545). The authors have no other conflicts of interest to declare. Data Sharing Statement Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0218/dss References Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0218/prf Supplementary Materials The article’s supplementary files as Data Availability Statement Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0218/dss